Local view for "http://purl.org/linkedpolitics/eu/plenary/2005-09-08-Speech-4-181"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20050908.27.4-181"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:translated text |
"The Moderate delegation has today voted in favour of a report on major and neglected diseases in the developing countries. We believe that disease and ill-health are dominant problems in these countries and that they are both causes and consequences of under-development.
However, we have our doubts about the EU expressing views on the way in which the pharmaceutical industry prices different products. We also have our doubts about forcing the pharmaceutical industry to reinvest a portion of its profits in R[amp]D in relation to neglected diseases. We should prefer to encourage the pharmaceutical industry voluntarily and for ethical and moral reasons to decide to re-invest a portion of its profits in research into diseases affecting poor countries. This is in line with assuming responsibility for global development.
What should also be drawn attention to are the African governments that deduct sales or import tax on antiretroviral and other medicines. This leads to medicines becoming unavailable to many impecunious groups. In those cases, the governments concerned must be strongly encouraged to abolish such taxes."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples